Attenuated expression of menin and p27 Kip1 in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor

Endocrine Journal

Volumn 58, Issue 4, 2011, Pages 287-296

  Ishida, Emi ^a   Yamada, Masanobu ^a   Horiguchi, Kazuhiko ^a   Taguchi, Ryo ^a   Ozawa, Atsushi ^a   Shibusawa, Nobuyuki ^a   Hashimoto, Koshi ^a   Satoh, Tetsuro ^a   Yoshida, Sachiko ^a   Tanaka, Yoshiki ^a   Yokota, Machiko ^a   Tosaka, Masahiko ^a   Hirato, Junko ^a   Yamada, Shozo ^b   Yoshimoto, Yuhei ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Atypical prolactinoma; MEN1; Menin; p18; p27

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; FOLLITROPIN; KI 67 ANTIGEN; MESSENGER RNA; METHIONINE; OCTREOTIDE; PROLACTIN; PROTEIN P53;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC ANALYSIS; HEMIPLEGIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL CARCINOMA; PANCREAS SURGERY; PATHOGENESIS; PROLACTINOMA; PROTEIN EXPRESSION; SPINE METASTASIS; TRANSSPHENOIDAL SURGERY; TUMOR RECURRENCE;

CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PITUITARY NEOPLASMS; PROLACTINOMA; PROTO-ONCOGENE PROTEINS;

EID: 79955758960     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-158     Document Type: Article

References (36)

1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA, Jr., Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658-5671.
2. Marx SJ (2005) Molecular Genetics of Multiple Endocrine Neoplasia types 1 and 2. Nat Rev Cancer 5: 367-375.
3. Glascock MJ, Carty SE (2002) Multiple endocrine neo plasia type 1: fresh perspective on clinical features and penetrance. Surg Oncol 11: 143-150.
4. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87: 457-465.
5. Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Verges B, Chabre O, Calender A (2008) Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 32: 534-543.
6. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 276: 404-407.
7. Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ (2007) The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. J Clin Endocrinol Metab. 92: 1948-1951.
8. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ (2006) Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 103: 15558-15563.
9. Agarwal SK, Mateo CM, Marx SJ (2009) Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 94: 1826-1834.
10. Wilson BS, Lloyd RV (1984) Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 115: 458-468.
11. Jin L, Hemperly JJ, Lloyd RV (1991) Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues. Am J Pathol 138: 961-969.
12. Horiguchi K, Yamada M, Satoh T, Hashimoto K, Hirato J, Tosaka M, Yamada S, Mori M (2009) Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue. Clin Cancer Res 15: 2620-2629.
13. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzilli R, Corinaldesi R (2005) Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol 16: 1806-1810.
14. Kars M, Roelfsema F, Romijn JA, Pereira AM (2006) Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155: 523-534.
15. Gordon MV, Varma D, McLean CA, Bittar RG, Burgess JR, Topliss DJ (2007) Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1). Clin Endocrinol (Oxf) 66: 150-152.
16. Gullo L, Migliori M, Falconi M, Pederzoli P, Bettini R, Casadei R, Delle Fave G, Corleto VD, Ceccarelli C, Santini D, Tomassetti P (2003) Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 98: 2435-2439.
17. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA (2006) Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 30: 654-662.
18. Sakurai A, Katai M, Yamashita K, Mori J, Fukushima Y, Hashizume K (2007) Long-term follow-up of patients with multiple endocrine neoplasia type 1. Endocr J 54: 295-302.
19. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A, Proye CA (2006) Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 243: 265-272.
20. Korbonits M, Chahal HS, Kaltsas G, Jordan S, Urmanova Y, Khalimova Z, Harris PE, Farrell WE, Claret FX, Grossman AB (2002) Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors J Clin Endocrinol Metab 87: 2635-2643.
21. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG, Grossman AB (1999) Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. J Clin Endocrinol Metab 84: 3823-3830.
22. Bamberger CM, Fehn M, Bamberger AM, Lüdecke DK, Beil FU, Saeger W, Schulte HM (1999) Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas. Eur J Endocrinol. 140: 250-255.
23. Komatsubara K, Tahara S, Umeoka K, Sanno N, Teramoto A, Osamura RY (2001) Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas. Endocr Pathol 12: 181-188.
24. Theodoropoulou M, Cavallari I, Barzon L, D'Agostino DM, Ferro T, Arzberger T, Grübler Y, Schaaf L, Losa M, Fallo F, Ciminale V, Stalla GK, Pagotto U (2004) Differential expression of menin in sporadic pituitary adenomas. Endocr Relat Cancer 11: 333-344.
25. Wrocklage C, Gold H, Hackl W, Buchfelder M, Fahlbusch R, Paulus W (2002) Increased menin expression in sporadic pituitary adenomas Clin Endocrinol 56: 589-594.
26. McCabe CJ, Gittoes NJ, Sheppard MC, Franklyn JA (1999) Increased MEN1 mRNA expression in sporadic pituitary tumours. Clin Endocrinol 50: 727-733.
27. Satta MA, Korbonits M, Jacobs RA, Bolden-Dwinfour DA, Kaltsas GA, Vangeli V, Adams E, Fahlbusch R, Grossman AB (1999) Expression of menin gene mRNA in pituitary tumours. Eur J Endocrinol 140: 358-361.
28. Hossain MG, Iwata T, Mizusawa N, Qian ZR, Shima SW, Okutsu T, Yamada S, Sano T, Yoshimoto K (2009) Expression of p18 (INK4C) is down-regulated in human pituitary adenomas. Endocr Pathol 20: 114-121.
29. Kirsch M, Mörz M, Pinzer T, Schackert HK, Schackert G. (2009) Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas. Genes Chromosomes Cancer 48: 143-154.
30. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385.
31. Palmqvist R, Stenling R, Oberg A, Landberg G (1999) Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization. J Pathol 188: 18-23.
32. Barbareschi M, van Tinteren H, Mauri FA, Veronese S, Peterse H, Maisonneuve P, Caffo O, Scaioli M, Doglioni C, Galligioni E, Dalla Palma P, Michalides R (2000) p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer 89: 236-241.
33. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL (2005) Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A 102: 749-754.
34. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M, Kim SK (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci U S A 102: 14659-14664.
35. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733-744.
36. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707-720.